10:02 AM EST - Valeant Pharmaceuticals International, Inc. : announced that it has agreed to acquire AB Sanitas for approximately EUR314 million in cash. The major shareholders of Sanitas have agreed to sell Valeant 87.2% of the outstanding shares of Sanitas, with at least 82.6% of the outstanding shares required to be delivered at closing. After the acquisition of this controlling block of shares, Valeant would commence a mandatory tender offer to acquire the remaining minority interest. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $0.64 at $48.96.
